Rocket One RKTO
NASDAQ RKTO
$0.67 -0.03 (-4.40%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rocket One (RKTO) Change in Account Payables (2018 - 2024)

Rocket One's (RKTO) quarterly Change in Account Payables came in at -$39305.0 in Q1 2024, up 16.77% year-over-year from -$33660.0 in Q2 2023, and up 96.83% quarter-over-quarter from -$1.2 million in Q4 2023.

Analysis

Rocket One (RKTO) Change in Account Payables (2018 - 2024) Analysis & Trends

Rocket One has disclosed Change in Account Payables across 7 years of filings, most recently posting -$39305.0 for Q1 2024.

  • In Q1 2024, Change in Account Payables rose 16.77% year-over-year to -$39305.0; the TTM figure through Mar 2024 stood at -$692832.0 (down 216.18% YoY), while the FY2023 annual figure was -$700752.0, down 218.64% from the prior year.
  • Change in Account Payables came in at -$39305.0 for Q1 2024 at Rocket One, up from -$1.2 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $453930.0 in Q1 2021 to a low of -$1.2 million in Q4 2023.
  • Average Change in Account Payables over 5 years is $13760.4, with a median of $102278.0 recorded in 2020.
  • Year-over-year, Change in Account Payables slumped 828.88% in 2021 and jumped 2571.93% in 2023.
  • Over 5 years, Change in Account Payables stood at $102278.0 in 2020, then tumbled by 828.88% to -$745481.0 in 2021, then jumped by 146.32% to $345336.0 in 2022, then tumbled by 458.74% to -$1.2 million in 2023, then soared by 96.83% to -$39305.0 in 2024.
  • Per Business Quant data, the three most recent Change in Account Payables figures were -$39305.0 in Q1 2024, -$1.2 million in Q4 2023, and $207182.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 7.11 Mn
10 Rocket One 13.86 Mn 5.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -39,305.00
Dec 31, 2023 -1.24 Mn
Sep 30, 2023 207,182.00
Jun 30, 2023 378,158.00
Mar 31, 2023 -47,225.00
Dec 31, 2022 345,336.00
Sep 30, 2022 284,058.00
Jun 30, 2022 14,153.00
Mar 31, 2022 -52,915.00
Dec 31, 2021 -745,481.00
Sep 30, 2021 412,793.00
Jun 30, 2021 414,098.00
Mar 31, 2021 453,930.00
Dec 31, 2020 102,278.00
Sep 30, 2020 -149,722.00
Jun 30, 2020 -218,219.00
Mar 31, 2020 113,675.00
Dec 31, 2019 384,324.00
Sep 30, 2019 -181,953.00
Jun 30, 2019 136,673.00